Your browser doesn't support javascript.
loading
Discordant Molecular Imaging Findings with 2-[18F]FDG and [68Ga]Ga-PSMA PET/CT in a Patient with Both Bladder and Prostate Cancer.
Mahalik, Aparna; Jaleel, Jasim; Sagar, Sambit; Khan, Dikhra; Raju, Shobhana; Kumar, Rakesh.
Afiliação
  • Mahalik A; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, 110029 India.
  • Jaleel J; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, 110029 India.
  • Sagar S; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, 110029 India.
  • Khan D; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, 110029 India.
  • Raju S; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, 110029 India.
  • Kumar R; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, 110029 India.
Nucl Med Mol Imaging ; 58(3): 150-151, 2024 May.
Article em En | MEDLINE | ID: mdl-38633286
ABSTRACT
The prevalence of double primary prostate and bladder cancer is not uncommon. Though both share a common pathway of malignant transformation, they bear to differ in the case of 2-[18F]FDG PET/CT and [68Ga]Ga-PSMA uptake. We present a case of double primary cancer involving the bladder and prostate, where the prostatic primary showed intense [68Ga]Ga-PSMA uptake with non-avid skeletal and pulmonary metastases, which showed intense 2-[18F]FDG uptake, thus showing discordance due to different clonal origins.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article